首页> 外文OA文献 >PD4-3-3: Phase II trial of carboplatin plus docetaxel combined with a selective cyclooxygenase-2 inhibitor (meloxicam) in first-line treatment of patients with advanced unresectable non-small cell lung cancer: anti-tumor effect and cyclooxygenase-2 expression

【2h】

PD4-3-3: Phase II trial of carboplatin plus docetaxel combined with a selective cyclooxygenase-2 inhibitor (meloxicam) in first-line treatment of patients with advanced unresectable non-small cell lung cancer: anti-tumor effect and cyclooxygenase-2 expression

机译：PD4-3-3：卡铂加多西他赛联合选择性环氧化酶2抑制剂（美洛昔康）在晚期不可切除的非小细胞肺癌患者的一线治疗中的II期试验：抗肿瘤作用和环氧化酶2表达

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sekine Satoko; Oshima Kengo; Ishida Takashi; Oizumi Satoshi; Yokouchi Hiroshi; Yamazaki Koichi; Sukoh Noriaki; Ogura Shigeaki; Munakata Mitsuru; Isobe Hiroshi;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer. [J] . Socinski MA, Raju RN, Stinchcombe T, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第12期

机译：培美曲塞和卡铂联合或不联合enzastaurin与多西他赛和卡铂作为IIB / IV期非小细胞肺癌患者的一线治疗的随机II期试验。
2. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [J] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Drugs in R&D . 2013,第4期

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
3. Elderly Subset Analysis of Randomized Phase?III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [J] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Drugs in R&D . 2013,第4期

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Cyclooxygenase-2 in non-small cell lung cancer: Mechanism of activation and therapeutic intervention. [D] . Csiki, Ildiko. 2004

机译：非小细胞肺癌中的环氧合酶2：激活机制和治疗干预。
6. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, -1

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
7. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . 2013

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析

PD4-3-3: Phase II trial of carboplatin plus docetaxel combined with a selective cyclooxygenase-2 inhibitor (meloxicam) in first-line treatment of patients with advanced unresectable non-small cell lung cancer: anti-tumor effect and cyclooxygenase-2 expression

著录项

引文网络

相似文献

相关主题

期刊订阅